Cargando…
Validating Trend-Based End Points for Neuroprotection Trials in Glaucoma
PURPOSE: The purpose of this study was to evaluate the power of trend-based visual field (VF) progression end points against long-term development of event-based end points accepted by the US Food and Drug Administration (FDA). METHODS: One eye from 3352 patients with ≥10 24-2 VFs (median = 11 years...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Association for Research in Vision and Ophthalmology
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619697/ https://www.ncbi.nlm.nih.gov/pubmed/37906055 http://dx.doi.org/10.1167/tvst.12.10.20 |